CareLit · DOI-Nachweis · Klinische Neurophysiologie
A novel BTX-formula with minimized protein envelope complex (Xeomin) in the treatment of patients with cervical dystonia and secondary response failure
DOI 10.1055/s-2006-939115
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Bussfeld, U Kahlen, H Hefter
ZeitschriftKlinische Neurophysiologie
Ausgabe03/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Due to development of neutralizing antibodies against Botuninumtoxin (BTX) and its complex of accompanying proteins, secondary response failure occurs in 1–5% of all patients with cervical dystonia (CD) treated with BTX over a period of several years. Whereas a development of neutralizing antibodies is boostered by high dosages and short treatment intervalls, a further component contributing to high anti…
Zitieren
Zitierempfehlung
P Bussfeld, U Kahlen, H Hefter (2006) A novel BTX-formula with minimized protein envelope complex (Xeomin) in the treatment of patients with cervical dystonia and secondary response failure. Klinische Neurophysiologie (03). https://doi.org/10.1055/s-2006-939115
Mit CareLit weiterarbeiten